Tower Research Capital (TRC)’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Tower Research Capital (TRC)’s Portfolio IQMDU Stock Details IQMDU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$3K	–	6600
2023 Q1	$3K	Buy	+300	New	+$3.07K	﹤0.01%	5294
2022 Q1	–	Sell	-60	Closed	-$1K	–	6901
2021 Q4	$1K	Buy	+60	New	+$608	﹤0.01%	5983

Other funds holding IQMDU

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return

Tower Research Capital (TRC)'s IQMDU Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q2 2023, closing a stake of 300 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in IQMDU in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q1 2023. 1 fund tracked by Wall St. Rank holds IQMDU as of Q2 2023.

Tower Research Capital (TRC) reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 300 Intelligent Medicine Acquisition Corp. Unit shares in Q2 2023, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
Tower Research Capital (TRC)'s Intelligent Medicine Acquisition Corp. Unit position peaked at $3K in Q1 2023.
1 fund tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.